gvtcx

Contracts for the supply of combined diphtheria, tetanus, and pertussis vaccines, with and without additional poliomyelitis antigen content

UK Health Security Agency Published 7 Jul 2023 Contracts Finder

key details

Statuscomplete
Category (CPV) 33651600
Deadline16 Feb 2023
Contract start1 Apr 2024
Contract end31 Mar 2028
Procedureopen
SME suitableNo
OCIDocds-b5fd17-407bef82-e123-4cb3-a899-98980426c26e

Award

SupplierValueDateStatus
DUPLICATE - Aventis Pharma Ltd Trading As Sanofi £1 21 Jun 2023 active

description

The provision of vaccines to protect against combined diphtheria, tetanus, and pertussis vaccines, with and without additional poliomyelitis antigen content, to be used in the national immunisation programme. Deliveries will be required over the initial term of 2 years and the contract has the option to be extended for up to an additional 24 months.

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
7 Jul 2023 Award (award) · 8f310d9e-1a83-4a2f-9f39-2ddf084df900-660689

more from UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.